BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND TSC1, KIAA0243, 7248, ENSG00000165699, TSC, MGC86987, LAM, hamartin AND Prognosis
7 results:

  • 1. Immunohistochemical comparative analysis of tumor stem cell biomarkers in pleomorphic adenoma, adenoid cystic carcinoma and mucoepidermoid carcinoma of salivary glands.
    Santos AAD; Mafra RP; da Silva LP; Pinto LP; Freitas RA; de Souza LB
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Mar; 135(3):396-409. PubMed ID: 36863971
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mutational Characteristics of Primary Mucosal Melanoma: A Systematic Review.
    Beaudoux O; Oudart JB; Riffaud L; Visseaux L; Marchal A; Lebre AS; Grange F
    Mol Diagn Ther; 2022 Mar; 26(2):189-202. PubMed ID: 35195858
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PIWIL2 interacting with IKK to regulate autophagy and apoptosis in esophageal squamous cell carcinoma.
    Zhao X; Huang L; Lu Y; Jiang W; Song Y; Qiu B; Tao D; Liu Y; Ma Y
    Cell Death Differ; 2021 Jun; 28(6):1941-1954. PubMed ID: 33469229
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Inhibition of miR-133b indicates poor prognosis and promotes progression of OSCC via SOX4.
    Yang J; Wang H; Xu W; Chen Z; Yan ZY; Zhang LJ
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12717-12726. PubMed ID: 33378019
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [cancer stem cell phenotypes and miRNA: therapeutic targets in head and neck squamous cell carcinoma].
    Coordes A; Zhifeng S; Sangvatanakul V; Qian X; Lenarz M; Kaufmann AM; Albers AE
    HNO; 2014 Dec; 62(12):867-72. PubMed ID: 25337967
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Hypoxia-inducible factor-1alpha polymorphisms and tsc1/2 mutations are complementary in head and neck cancers.
    Hebert C; Norris K; Parashar P; Ord RA; Nikitakis NG; Sauk JJ
    Mol Cancer; 2006 Jan; 5():3. PubMed ID: 16412252
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management.
    Zhang L; Cheung KJ; Lam WL; Cheng X; Poh C; Priddy R; Epstein J; Le ND; Rosin MP
    Cancer; 2001 Jun; 91(11):2148-55. PubMed ID: 11391596
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.